Actively Recruiting
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study
Led by ARCIM Institute Academic Research in Complementary and Integrative Medicine · Updated on 2025-01-08
200
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
A
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Lead Sponsor
G
Gemeinschaftskrankenhaus Herdecke, Germany
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are observing how often antibiotics are prescribed to children hospitalized with community-acquired pneumonia and how doctors decide whether antibiotics are needed. The study also records parental satisfaction with the treatment process. It focuses on a pediatric department known for cautious antibiotic use. This observational study aims to understand treatment patterns and outcomes without altering standard care. Children with non-severe community-acquired pneumonia and fever will be followed either with antibiotic treatment or without antibiotics, depending on the attending physician's decision according to hospital procedures. These two groups include children managed with antibiotics and those managed without. Treatment follows the hospital's standard operating procedures without experimental interventions. During the hospital stay, which averages about 7 days, researchers will track antibiotic use rates, disease severity, medical complications, oxygen use, medication use, and hospital stay duration. Parents will be contacted at least 4 weeks after discharge to check for pneumonia recurrence or readmission. Parental satisfaction with care during hospitalization will also be assessed.
CONDITIONS
Brief Title
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospital admission at the pediatric department of the Filderklinik or the Herdecke Community Hospital
- Diagnosis of pneumonia at admission or within 48 hours after admission
- Written informed consent provided by the caregiver
- All inclusion criteria must be met
You will not qualify if you...
- Insufficient knowledge of German to understand written patient information and questionnaires for participation in the study and related assessments
- Failure to meet any inclusion criteria excludes participation in the study
- Inability to provide informed consent by caregiver
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 7 days
Participants hospitalized with community-acquired pneumonia are observed during their hospital stay for antibiotic treatment use, medical complications, and other health factors according to standard care.
Daily assessments during hospitalization
Duration - 4 weeks after hospital discharge
Parents are contacted to assess recurrence or readmission for pneumonia within 4 weeks after hospital discharge.
1 follow-up contact (phone or in-person)
Trial Site Locations
Total: 2 locations
1
Die Filderklinik
Filderstadt, Baden-Wurttemberg, Germany, 70794
Actively Recruiting
2
Herdecke Community Hospital
Herdecke, North Rhine-Westphalia, Germany, 58313
Actively Recruiting
Research Team
J
Jan Vagedes, Dr
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here